- In October 2023, Cambridge Cognition introduced AQUA, the inaugural automated quality assurance (QA) solution designed for central nervous system (CNS) clinical trials. AQUA, leveraging Winterlight's speech and language platform, employs audio recordings from patient consultations to detect errors in the administration and scoring of cognitive assessments.
- In June 2023, Cogstate introduced new learning modules for the majority of its digital tests, aimed at improving the accuracy of self-assessment data in remote clinical trials. The company made progress in the validation of smartphone tests for deploying Cogstate assessments in clinical trials and for individuals interested in monitoring their brain health through the company's Lila app
- In May 2023, Linus Health, a digital health solution provider, announced the result of its digital cognitive assessment solution study with a commonly used, paper-based cognitive test, the Mini-Mental State Examination (MMSE), in detecting cognitive cases of impairment. This solution helps in the earlier identification of cognitive issues
- In January 2022, Eisai Co., Ltd. announced the launch of CogMate by its Taiwanese and Hong Kong subsidiaries. CogMate is a digital tool for self-assessment of brain health and is expected to be launched in other countries including Singapore
- In September 2020, Signant Health has launched a new Master Class web series which is designed specifically to boost the understanding skills of clinical operations professionals which are interested in electronic clinical outcome assessments (eCOA). The complimentary and educational class launches deal among three courses along with 16 on-demand lessons that is designed for all levels of eCOA experience taught by clinical research science and technology experts. The company is going to enhance its business portfolio turning more income for it
